Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 21070777)

1.

Rescue of lethal hepatic failure by hepatized lymph nodes in mice.

Hoppo T, Komori J, Manohar R, Stolz DB, Lagasse E.

Gastroenterology. 2011 Feb;140(2):656-666.e2. doi: 10.1053/j.gastro.2010.11.006. Epub 2010 Nov 9.

2.

Therapeutic liver reconstitution with murine cells isolated long after death.

Erker L, Azuma H, Lee AY, Guo C, Orloff S, Eaton L, Benedetti E, Jensen B, Finegold M, Willenbring H, Grompe M.

Gastroenterology. 2010 Sep;139(3):1019-29. doi: 10.1053/j.gastro.2010.05.082. Epub 2010 Jun 2.

3.

Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.

Aponte JL, Sega GA, Hauser LJ, Dhar MS, Withrow CM, Carpenter DA, Rinchik EM, Culiat CT, Johnson DK.

Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):641-5.

4.

The mouse lymph node as an ectopic transplantation site for multiple tissues.

Komori J, Boone L, DeWard A, Hoppo T, Lagasse E.

Nat Biotechnol. 2012 Oct;30(10):976-83. doi: 10.1038/nbt.2379. Epub 2012 Sep 23.

5.

High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice.

Eggenhofer E, Doenecke A, Renner P, Slowik P, Piso P, Geissler EK, Schlitt HJ, Dahlke MH, Popp FC.

J Gastroenterol Hepatol. 2010 May;25(5):1002-8. doi: 10.1111/j.1440-1746.2009.06156.x.

PMID:
20546455
6.

Hepatic tissue environment in NEMO-deficient mice critically regulates positive selection of donor cells after hepatocyte transplantation.

Kaldenbach M, Cubero FJ, Erschfeld S, Liedtke C, Trautwein C, Streetz K.

PLoS One. 2014 Jun 30;9(6):e100786. doi: 10.1371/journal.pone.0100786. eCollection 2014.

7.

Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation.

Nagata H, Ito M, Cai J, Edge AS, Platt JL, Fox IJ.

Gastroenterology. 2003 Feb;124(2):422-31.

PMID:
12557148
8.

Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.

Luijerink MC, van Beurden EA, Malingré HE, Jacobs SM, Grompe M, Klomp LW, Berger R, van den Berg IE.

Kidney Int. 2004 Sep;66(3):990-1000.

PMID:
15327392
9.

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.

Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, Yang VW, Lee OK.

Gastroenterology. 2008 Jun;134(7):2111-21, 2121.e1-3. doi: 10.1053/j.gastro.2008.03.015. Epub 2008 Mar 12.

10.

Transplanted bone marrow regenerates liver by cell fusion.

Vassilopoulos G, Wang PR, Russell DW.

Nature. 2003 Apr 24;422(6934):901-4. Epub 2003 Mar 30.

PMID:
12665833
11.

Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice.

Navarro-Alvarez N, Soto-Gutierrez A, Chen Y, Caballero-Corbalan J, Hassan W, Kobayashi S, Kondo Y, Iwamuro M, Yamamoto K, Kondo E, Tanaka N, Fox IJ, Kobayashi N.

J Hepatol. 2010 Feb;52(2):211-9. doi: 10.1016/j.jhep.2009.11.019. Epub 2009 Dec 8.

PMID:
20022655
12.

Allogeneic bone marrow transplantation restores liver function in Fah-knockout mice.

Eggenhofer E, Popp FC, Renner P, Slowik P, Neuwinger A, Piso P, Geissler EK, Schlitt HJ, Dahlke MH.

Exp Hematol. 2008 Nov;36(11):1507-13. doi: 10.1016/j.exphem.2008.05.010. Epub 2008 Aug 19.

PMID:
18715687
13.

Animal models of tyrosinemia.

Nakamura K, Tanaka Y, Mitsubuchi H, Endo F.

J Nutr. 2007 Jun;137(6 Suppl 1):1556S-1560S; discussion 1573S-1575S. Review.

14.

Primary human hepatocyte transplantation in the therapy of hepatic failure: 2 cases report.

Li ZR, Mao XH, Hu XX, Nie SD, Shi YZ, Xiang H, Yang JH, Cao OD.

Asian Pac J Trop Med. 2012 Feb;5(2):165-8. doi: 10.1016/S1995-7645(12)60018-2.

15.

Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity.

Jacobs SM, van Beurden DH, Klomp LW, Berger R, van den Berg IE.

Pediatr Res. 2006 Mar;59(3):365-70.

PMID:
16492973
16.

Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.

Kaldenbach M, Giebeler A, Tschaharganeh DF, Erschfeld S, Wasmuth HE, Dolle L, Floege J, Trautwein C, Streetz KL.

Gut. 2012 Aug;61(8):1209-18. doi: 10.1136/gutjnl-2011-301345. Epub 2012 Jan 27.

PMID:
22287599
17.

Intrasplenic hepatocyte transplantation prolonged the survival in Nagase analbuminemic rats with liver failure induced by common bile duct ligation.

Ito M, Nagata H, Yamamoto T, Yoshihara D, Fox IJ, Miyakawa S.

Cell Transplant. 2007;16(5):547-53.

PMID:
17708344
18.

The origin and liver repopulating capacity of murine oval cells.

Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M.

Proc Natl Acad Sci U S A. 2003 Sep 30;100 Suppl 1:11881-8. Epub 2003 Aug 5.

19.

Intrablastocyst injection with human CD34+/CD133+ cells increase survival of immunocompetent fumarylacetoacetate hydrolase knockout mice.

Marra E, Turrini P, Tripodi M, Ciliberto G, Padron J, Aurisicchio L.

Lab Anim. 2012 Oct;46(4):280-6. doi: 10.1258/la.2012.012038.

PMID:
23097560
20.

Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.

Azuma H, Paulk N, Ranade A, Dorrell C, Al-Dhalimy M, Ellis E, Strom S, Kay MA, Finegold M, Grompe M.

Nat Biotechnol. 2007 Aug;25(8):903-10. Epub 2007 Jul 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk